Re: Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.

Yoshii, Y; Ikeda, K; Iwamoto, K; Kawase, Y; Iwasaki, Y

Yoshii, Y; Ikeda, K; Iwamoto, K; Kawase, Y; Iwasaki, Y.

Neurology ; 72(10): 944; author reply 944-5, 2009 Mar 10.

Article in En | MEDLINE | ID: mdl-19273834

Subject(s)

Amyotrophic Lateral Sclerosis/complications; Amyotrophic Lateral Sclerosis/metabolism; Dyslipidemias/complications; Dyslipidemias/metabolism; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects; Hypolipidemic Agents/adverse effects; Neuroprotective Agents; Animals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Hypolipidemic Agents/therapeutic use; Mice; Mice, Neurologic Mutants; Muscle Contraction/physiology; Species Specificity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroprotective Agents / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Dyslipidemias / Amyotrophic Lateral Sclerosis / Hypolipidemic Agents Limits: Animals / Humans Language: En Journal: Neurology Year: 2009 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google